Niklas Anzinger
Niklas Anzinger is the Founder and CEO of Infinita City and General Partner of Infinita VC, with over 10 years of experience in venture capital, startups, and regulatory innovation.
As the founder of Infinita VC, a venture capital firm based in the charter city of Próspera in Honduras..He leverages special economic zones and enables legislation to unlock “stranded technologies” — innovations held back by traditional regulatory frameworks.
Operating within Prospera, Infinita is building a biotech-focused district that demonstrates how competitive governance can foster development. He pursues a decentralized strategy with 3–5 physical hubs, starting with Prospera and expanding to innovative US states like Montana under its SB 535 right-to-try framework.
At Infinita City since January 2025, previously known as Vitalia since 2023, Niklas builds a network city for longevity biotech acceleration with the goal of making death optional. Infinita, which has $6 million in investment, a permanent community and regular events, seeks to optimize conditions for rapid advancements in medical research while maintaining adaptability to diverse regulatory landscapes.
Niklas advocates for reducing drug development timelines from 10 years to 6 months, noting the FDA had a 6-month deadline before 1962. His vision includes competitive jurisdictions offering regulatory flexibility where businesses choose which country’s regulations apply.Listen to Stranded Technologies Podcast and read the Infinita Manifesto 2.0.
Currently, Vitalia/Infinita has 25–30 full-time residents and three biotech companies: Minicircle, Unlimited Bio, and Symbiont Labs. Infinita has also established a new clinic and a new academic program to build foundational institutions for a lasting city development for biomedical acceleration.
Niklas uses a layer analogy for Infinita’s structure: philosophy and legal governance are ‘layer zero’, Prospera is a ‘layer one’ governance platform, and Infinita is a ‘layer two’ platform that builds an industry based on community. He explains that Infinita’s role as a layer two is to reduce transaction costs to allow more applications to be built on top of the layer ones.” Credit to Balaji Srinivasan for this distinction.
The regulatory flexibility of Prospera addresses “Eroom’s Law”, which is the observation that drug discovery is becoming slower and more expensive over time, despite improvements in technology (such as high-throughput screening, biotechnology, combinatorial chemistry, and computational drug design), a trend first observed in the 1980s. Read Eroom’s Law | Science | AAAS.
Niklas sees parallels between the longevity and crypto communities, including a shared ethos of questioning centralized systems and viewing institutions like the FDA as bottlenecks to progress. He believes the transition to more privatized and decentralized systems is already underway, with governments competing for talent and investment, and sees projects like Prospera as key steps in creating a “Cambrian explosion” of new jurisdictions and network states.
Infinita received backing from Balaji Srinivasan, Boost VC, North Island Ventures, Winklevoss Capital and Tim Draper.
As General Partner at Infinita VC since 2022, Niklas identifies founders overcoming regulatory bottlenecks. Investment Range $50K – $200K. The fund focuses on seed-stage investments in biotechnology, hardware and crypto.. The portfolio includes drone delivery, robotic construction, and gene therapy startups. Read Niklas Anzinger’s Investing Profile – Infinita Fund General Partner | Signal.
Minicircle, a portfolio company, conducted follistatin gene therapy trials in Prospera. The company that produced and delivered Bryan’s therapy, is one of the pioneers in human genetic enhancement.Bryan Johnson opted for follistatin gene therapy and travel to Prospera, as the procedure isn’t available in the U.S.Read What Is Minicircle? Bryan Johnson’s Honduras Gene Therapy Company From Netflix’s Don’t Die Explained.
Niklas hosts the Stranded Technologies Podcast, where he interviews leading entrepreneurs, investors, and thinkers about competitive governance and regulatory innovation. In the podcast, Niklas talks and writes about his experience as a VC based in Prospera, Honduras, and how competitive governance can unblock “stranded technologies” that are held back by bureaucracy and overregulation.Notable guests have included Tyler Cowen, Naval Ravikant, Balaji Srinivasan, Brian Armstrong, and Bradley Tusk. Listen to Stranded Technologies Podcast – Niklas Anzinger | Listen Notes.
Watch To Infinita and Beyond with Niklas Anzinger, Longevity, Crypto, and Network States, Building a New Biotech Jurisdiction @ LBF + Longevity Workshop 2024, and A Longevity City District in Prospera | Niklas Anzinger | Startups Societies Conference.
Visit his LinkedIn profile, his Substack page, and his Signal profile. Follow him on YouTube, Facebook, Instagram, X, Crunchbase, and listen to his Stranded Technologies Podcast.